Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Send this study to a contact
1
Your personal information
Your name
Your e-mail
Send me a copy
2
Your recipient's information
The name of your contact
Your contact email
3
Your message
Votre message
A Double-Blind, Randomized, Parallel, Two-Arm Phase II Trial of BMS-690514 versus Erlotinib in Previously Chemotherapy Treated Non-Small Cell Lung Cancer Patients Estudio Fase II doble ciego, aleatorizado, de grupos paralelos, de BMS-690514 frente a erlotinib en pacientes con cáncer de pulmón no microcítico previamente tratados con quimioterapia. Revised Protocol Number 01, incorporating amendment 03 + Pharmacogenetics Blood Sample Amendment 01 (version 1.0 dated 30-Jul-08) + Protocol Amendment 02 FDG-PET Sub-Study (version 1.0 dated 19-Sep-08) https://kusajili.com:443/Trial/ATD9Xu3QTUqkceNZw3wEsQ%24a-double-blind-randomized-parallel-two-arm-phase-ii-trial-of-bms-690514-versus-erlotinib-in-previously-chemotherapy-treated-non
I have read and accept the terms of use of the site and the Privacy Policy
Send your message